Proprietary Affibody® molecules and Albumod platforms. 4 clinical / late-stage, proprietary programs including psoriasis, B-cell autoimmune diseases, & liver diseases. Pipeline also includes Dx imaging program targeting metastatic breast cancer.
Phase l or ll
Autoimmune, Dermatology, Oncology, Rare Disease
Antibodies, Platform Technology
Gunnar Asplunds Allé 24, SE-171 69
Solna, , 17169
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.